Overview

Overview

Corporate Profile

Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Recent NewsMore >>
Stock Quote
NVAX (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$0.99
Change (%) Stock is Down 0.05 (4.81%)
Volume4,360,677
Data as of 05/26/17 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.